Collegium Pharmaceutical (COLL) Consolidated Net Income: 2014-2024
Historic Consolidated Net Income for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $42.4 million.
- Collegium Pharmaceutical's Consolidated Net Income rose 237.51% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 34.03%. This contributed to the annual value of $42.4 million for FY2024, which is 7.88% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Consolidated Net Income stood at $42.4 million for FY2024, which was down 7.88% from $46.0 million recorded in FY2023.
- Over the past 5 years, Collegium Pharmaceutical's Consolidated Net Income peaked at $71.5 million during FY2021, and registered a low of -$33.6 million during FY2022.
- For the 3-year period, Collegium Pharmaceutical's Consolidated Net Income averaged around $18.3 million, with its median value being $42.4 million (2024).
- Per our database at Business Quant, Collegium Pharmaceutical's Consolidated Net Income tumbled by 146.92% in 2022 and then spiked by 237.10% in 2023.
- Over the past 5 years, Collegium Pharmaceutical's Consolidated Net Income (Yearly) stood at $26.8 million in 2020, then spiked by 167.33% to $71.5 million in 2021, then plummeted by 146.92% to -$33.6 million in 2022, then soared by 237.10% to $46.0 million in 2023, then fell by 7.88% to $42.4 million in 2024.